VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis. Blood. 2018 10 18; 132(16):1664-1674.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Azacitidine
Female
Follow-Up Studies
Humans
Male
Middle Aged
Nitriles
Primary Myelofibrosis
Prognosis
Prospective Studies
Pyrazoles
Pyrimidines
Safety
Survival Rate
authors with profiles
CARLOS E BUESO-RAMOS
RAJYALAKSHMI LUTHRA
ZEEV ESTROV
JORGE E CORTES
FARHAD RAVANDI-KASHANI
SRDAN VERSTOVSEK
GUILLERMO GARCIA-MANERO
YESID ALVARADO
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA
MARO OHANIAN
NAVEEN PEMMARAJU
KEYUR PRAVINCHANDRA PATEL
NAVAL DAVER
COURTNEY DINARDO
KOICHI TAKAHASHI
KAPIL BHALLA
PRITHVIRAJ BOSE
HAGOP M KANTARJIAN